FDA Adverse Event Malfunction Summary report: N

T:SLIM G5 SYSTEM

MDR report key: 7915898 · Received September 27, 2018

Report

Report Number
3013756811-2018-34534
Event Type
Malfunction
Date Received
September 27, 2018
Date of Event
September 12, 2018
Report Date
September 27, 2018
Manufacturer
TANDEM DIABETES CARE
Product Code
OYC
UDI-DI
00853052007257532071
PMA / PMN Number
P140015
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE X2 USER GUIDE STATE ¿HUMALOG® OR NOVOLOG® . ONLY HUMALOG® AND NOVOLOG® HAVE BEEN TESTED AND FOUND TO BE COMPATIBLE FOR USE IN THE SYSTEM. USE OF INSULIN WITH LESSER OR GREATER CONCENTRATION CAN RESULT IN UNDER DELIVERY OR OVER DELIVERY OF INSULIN. THIS CAN CAUSE VERY HIGH OR A VERY LOW BLOOD GLUCOSE.¿ PER TANDEM¿S USER GUIDE: ¿NEVER FILL YOUR TUBING WHILE YOUR INFUSION SET IS CONNECTED TO YOUR BODY. ALWAYS ENSURE THAT THE INFUSION SET IS DISCONNECTED FROM YOUR BODY BEFORE FILLING THE TUBING. FAILURE TO DISCONNECT YOUR INFUSION SET FROM YOUR BODY BEFORE FILLING THE TUBING CAN RESULT IN OVER DE¬LIVERY OF INSULIN. THIS CAN CAUSE SERIOUS INJURY OR DEATH FROM VERY LOW BLOOD GLUCOSE.¿ NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT MULTIPLE MINIMUM FILL NOTIFICATIONS OCCURRED AFTER FILLING MULTIPLE CARTRIDGES WITH 120-140 UNITS OF INSULIN. ADDITIONALLY, IT WAS REPORTED THAT THE CUSTOMER FILLED TUBING WHILE CONNECTED AT THE SITE. REPORTEDLY, A NEW CARTRIDGE WAS LOADED SUCCESSFULLY AND INSULIN DELIVERY WAS RESUMED. THE CUSTOMER¿S BLOOD GLUCOSE LEVEL REACHED 221-301 MG/DL.

Description of Event or Problem · 1

CUSTOMER LOADED HUMALIN U100 INTO THE CARTRIDGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
754939 T:SLIM G5 SYSTEM CONTINUOUS GLUCOSE MONITOR OYC TANDEM DIABETES CARE 1000096 M022071 00853052007257532071

Patients

Seq Age Sex Outcome Treatment
1 64 YR